Related Experiment Video
Updated: Jan 22, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the
Suzanne C Li1,2, Robert C Fuhlbrigge3, Ronald M Laxer4
1Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Imus PC337, 30 Prospect Ave, Hackensack, NJ, 07061, USA. suzanne.li@hackensackmeridian.org.
This pilot study shows that comparative effectiveness research for juvenile localized scleroderma (jLS) is feasible. Multi-center collaboration and standardized protocols are key to studying rare pediatric diseases.
Area of Science:
- Rheumatology
- Pediatrics
- Clinical Research
Background:
- Limited evidence exists for optimal juvenile localized scleroderma (jLS) therapy.
- A pilot comparative effectiveness study was designed to address this gap.
- The study also evaluated strategies for rare pediatric disease research.
Purpose of the Study:
- To assess the feasibility of conducting a comparative effectiveness study for jLS.
- To identify effective strategies for implementing research in rare pediatric diseases.
- To evaluate standardized methotrexate-based treatment regimens for jLS.
Main Methods:
- Prospective, multi-center, observational cohort study of 50 jLS patients.
- Patients received one of three standardized methotrexate-based consensus treatment plans (CTPs).
- Study conducted by the Childhood Arthritis and Rheumatology Research Alliance (CARRA) from 2012-2015, including a bio-banking sub-study.
Main Results:
- Achieved target enrollment of 50 jLS patients across 10 sites within 26 months.
- Eligibility criteria effectively captured appropriate patients for treatment studies.
- High study completion rate (88%) and significant bio-banking participation (68%) were observed.
Conclusions:
- The approach is feasible for comparative effectiveness research in rare pediatric diseases.
- Multi-center collaboration among dedicated investigators is crucial for success.
- Sufficient investigator numbers and streamlined study management facilitate rare disease research.
Related Concept Videos
Case Studies
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Pilot and Numeric Relaying
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

